Nutrition :: Cognis to launch Omevital, omega-3 fatty acids at HiE

Cognis will unveil its new range of high quality omega-3 fish oil products at this year?s Health Ingredients Europe event in Frankfurt. Under the brand name Omevital?, and available in ethyl ester and triglyceride forms, the new range of marine-origin oils delivers products of outstanding quality and purity, ultra-refined through state-of-the-art manufacturing processes, in accordance with Pharma GMP standards.

?Omevital? offers tremendous opportunities to enhance food and food supplement products with some of the finest omega-3 fish oils on the market?, said Petra M?ller, Global Product Line Manager for Omevital?. ?Cognis is able to offer consistent supply from high quality sustainable sources, and extensive quality control ensures excellent standards of purity. The range is positioned to enable customers to profit from the escalating consumer demand for these polyunsaturated fatty acids?, she said.

After decades of study, the long-chain fatty acids EPA and DHA have been scientifically proven to have health benefits for the heart. Crucially, this body of evidence has resulted in approved health claims that can drive product sales. Market surveys have confirmed that consumers are not only aware of omega-3 fatty acids, but that their highlighted presence encourages product purchase.

Now, as scientific data accumulates, there is keen interest in the potential benefits of omega-3 fatty acids for the brain – a health platform that the Cognis team is examining closely.

With the launch of Omevital? omega-3 fatty acids, Cognis Nutrition & Health has added a significant new member to its existing family of premium ingredients that provide scientifically-proven, marketable health benefits: Tonalin? CLA natural source conjugated linoleic acid*; Vegapure? plant sterols and sterol esters; and Xangold? natural lutein esters.

Omevital? is produced at the state-of-the-art facilities of Napro Pharma, now a fully-owned member of the Cognis Group. Founded in 1986 and located in Brattvaag on the west coast of Norway, Napro Pharma has vast experience in producing high quality omega-3 fish oil products for the nutrition industry.

*Tonalin? conjugated linoleic acid is an exclusively licensed product of the Cognis Group.

About Cognis:
Cognis is a worldwide supplier of innovative specialty chemicals and nutritional ingredients. The company employs about 8,000 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural-source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, textiles, as well as agriculture and mining. The company holds a 50-percent stake in Cognis Oleochemicals, one of the world?s leading manufacturers of natural-source oleochemical basestocks.

Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2005, Cognis recorded sales of 3.18 billion euros and an Adjusted EBITDA (earnings before interest, income taxes, depreciation, amortization and exceptional items) of 356 million euros.

Leave a Comment